7-99876805-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001005276.1(OR2AE1):āc.229A>Gā(p.Ile77Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,613,862 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I77T) has been classified as Likely benign.
Frequency
Consequence
NM_001005276.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2AE1 | NM_001005276.1 | c.229A>G | p.Ile77Val | missense_variant | 1/1 | ENST00000316368.3 | NP_001005276.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2AE1 | ENST00000316368.3 | c.229A>G | p.Ile77Val | missense_variant | 1/1 | 6 | NM_001005276.1 | ENSP00000313936.2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151904Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000282 AC: 71AN: 251456Hom.: 1 AF XY: 0.000309 AC XY: 42AN XY: 135896
GnomAD4 exome AF: 0.000191 AC: 279AN: 1461840Hom.: 2 Cov.: 34 AF XY: 0.000249 AC XY: 181AN XY: 727228
GnomAD4 genome AF: 0.000145 AC: 22AN: 152022Hom.: 0 Cov.: 30 AF XY: 0.000162 AC XY: 12AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.229A>G (p.I77V) alteration is located in exon 1 (coding exon 1) of the OR2AE1 gene. This alteration results from a A to G substitution at nucleotide position 229, causing the isoleucine (I) at amino acid position 77 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at